Vera Therapeutics VERA Ratios (2026)

NASDAQ VERA
$30.04 -0.57 (-1.86%)
As of: Nov 10, 2026 · 2:14 PM EST
Reported Financials

Vera Therapeutics Quarterly Ratios

Periods 1 quarter
Latest Sep 2026

Vera Therapeutics reported a gross margin of 67.93% and a net margin of -911.85% for the quarter ended Sep 2026. These financial ratios cover 1 quarter of results, standardized by Business Quant from the company’s SEC filings.

Vera Therapeutics Ratios API

Pull Vera Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=VERA&statement=Ratios&frequency=Quarter&period=all&api_key=YOUR_API_KEY